NasdaqGS - Nasdaq Real Time Price
USD
BioCryst Pharmaceuticals, Inc. (BCRX)
8.45
+0.07
(+0.90%)
As of 1:52:56 PM EDT. Market Open.
Trade BCRX on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutBioCryst highlighted new clinical and real-world data for ORLADEYO and investigational navenibart ahead of its November 4 earnings release. The FDA also approved an ORLADEYO pellet formulation, expanding dosing options, while competition from Pharvaris remains a central issue for the company’s long-term growth outlook.
No news stories available
